Catalyst Pharmaceuticals(CPRX) - 2019 Q2 - Quarterly Report

Table of Contents Title of Each ClassTicker Symbol(s)Name of Exchange on Which Registered Common Stock, par value $0.001 per share CPRX NASDAQ Capital Market Large accelerated filer ☐ Accelerated Filer ☒ Non-accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 OR ...